BioNTech - Latest News, Analysis, Opinion

UK authorises Pfizer, BioNTech COVID-19 vaccines, delivery from next week

Pfizer, BioNTech submit application to register COVID-19 vaccine in EU

Pfizer, BioNTech submit application to register COVID-19 vaccine in EU

Pfizer-BioNTech Apply For EU Emergency Authorization For COVID-19 Vaccine

Companies & Markets

The application to the European Medicines Agency (EMA) comes after the companies applied for U.S. approval on Nov. 20, taking them a step closer to launching their vaccine.

Moderna To Charge $25-$37 For COVID-19 Vaccine, CEO Tells Paper

Health

Moderna has said its experimental vaccine is 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial, becoming the second developer to report results that far exceeded expectations after Pfizer and its partner BioNTech.

Pfizer, BioNTech to submit to FDA for emergency use authorisation for their COVID-19 vaccine candidate

Pfizer, BioNTech to submit to FDA for emergency use authorisation for their COVID-19 vaccine candidate

EU Could Pay Over $10 Billion For Pfizer And Curevac Vaccines

Health

The EU has separately agreed to pay 10 euros ($11.84) per dose for an initial supply of 225 million doses of the vaccine candidate from CureVac, a discount from the 12 euros the company set as the price for the shot, the official said.

Pfizer, BioNTech offer Brazil COVID-19 vaccination plan for 2021

Pfizer, BioNTech offer Brazil COVID-19 vaccination plan for 2021

Pfizer, BioNTech Conclude Phase 3 Study Of COVID-19 Vaccine Candidate, Say It's 95% Effective

Healthcare Pharma

The major announcement comes just two days after leading biotechnology company Moderna said on Monday its virus vaccine had an efficacy rate of 94.5 per cent

Pfizer says Covid-19 vaccine trial complete, cites shot is 95 per cent effective

Pfizer says Covid-19 vaccine trial complete, cites shot is 95 per cent effective

Spain Authorises Phase III Trial Of Johnson & Johnson COVID-19 Vaccine

Health

The Phase III trial of the two-dose vaccination will be carried out in nine hospitals throughout Spain on volunteers both with and without previous health conditions

S&P 500 Hits All-Time Closing High After Earnings, Oil Drops On Pandemic Worry

Companies & Markets Markets Stock Market

The Dow Jones Industrial Average rose 399.64 points, or 1.37%, to 29,479.81, the S&P 500 gained 48.14 points, or 1.36%, to 3,585.15 and the Nasdaq Composite added 119.70 points, or 1.02%, to 11,829.29.

BioNTech says no infomation on vaccination start in Germany

BioNTech says no infomation on vaccination start in Germany

Nasdaq Retreats As Technology Stocks Lose Favor

Companies & Markets Markets Stock Market

The Dow Jones Industrial Average rose 262.95 points, or 0.9%, to 29,420.92, the S&P 500 lost 4.97 points, or 0.14%, to 3,545.53 and the Nasdaq Composite dropped 159.93 points to 11,553.86.

Oil Gains Nearly 3% On Vaccine Hopes, Even As Nations Reimpose Lockdowns